Watford, England medtech company founded 1856; makes the CORI handheld CT-free robotic system, the first cleared in the US for revision knee surgery.
Smith+Nephew plc is a medical technology company that traces its origin to a chemist shop opened by Thomas James Smith in Hull, England, in 1856, formally established as T.J. Smith and Nephew in 1896. The company is headquartered in Watford, England, employs approximately 17,000 people across around 100 countries, and is listed on the London Stock Exchange, a FTSE 100 constituent since 2001, and on the New York Stock Exchange.
Beyond wound management, sports medicine and ENT products, its orthopaedics robotics line centers on the CORI Surgical System, a portable, handheld, CT-free robotic-assisted platform that uses image-agnostic smart mapping to build a 3D model of the joint during surgery rather than from pre-operative scans. CORI holds FDA 510(k) clearance for total, partial and revision knee arthroplasty, the first robotic system cleared in the US for revision knee surgery, and a software-only RI.HIP NAVIGATION module extends its planning tools to total hip replacement. In 2026, Smith+Nephew introduced the next-phase CORI XT platform, extending robotic assistance toward hip and shoulder arthroplasty.
A CORIOGRAPH pre-operative planning add-on for CORI users was introduced in 2024.
Primary type & automation activities this supplier delivers:
CT-free handheld robotic-assisted orthopaedic surgery platform for knee, hip, and shoulder arthroplasty, with intraoperative 3D bone mapping.
Contact Smith+Nephew
WEBSITE
https://smith-nephew.comPHONE
+44 1923 477100HEADQUARTERS
United Kingdom
Company Facts
Founded
1856
Primary Role
Manufacturer
Company Size
-
Primary Region
Europe
Annual Sales
-
Funding Stage
-
Funding Total
-
Certifications & Memberships